Save Comparison | ![]() Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | ![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ![]() Clinigen Group A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time | ![]() Recro Gainesville Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |
Founding Date | Founding Date N/A | Founding Date 1998 | Founding Date 2002 | Founding Date 2010 | Founding Date 2006 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cupertino, US HQ | Locations Boulder, US HQ Cambridge, US Chicago, US Detroit, US Houston, US Miami, US Morrisville, US see more | Locations Cranbury Township, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin 15, IE Milano, IT see more | Locations Burton upon Trent, GB HQ Warriewood, AU Chuo City, JP Singapore, SG Pretoria, ZA Hobson, GB London, GB see more | Locations Malvern, US HQ Gainesville, US Gainesville, US |
Employees | Employees 902% increase | Employees 29843% increase | Employees 58415% increase | Employees 1,13342% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) 467.3 m | Valuation ($) N/A | Valuation ($) 5.5 b | Valuation ($) 1.3 b | Valuation ($) 76.8 m |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.7 k | Twitter followers 1.4 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.6 | Average likes per tweet (last 30 days) 1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 197124 | Alexa Website Rank N/A | Alexa Website Rank 304877 | Alexa Website Rank 645582 | Alexa Website Rank 186566 |
Employee Rating | Employee Rating 3.5 | Employee Rating 3.5 | Employee Rating 3 | Employee Rating 2.8 | Employee Rating 4.1 |
Financial | |||||
Revenue (est.) | Revenue (est.) $29.6m (FY, 2019) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $182.2m (FY, 2019) | Revenue (est.) £456.9m (FY, 2019) | Revenue (est.) $99.2m (FY, 2019) |
Cost of goods | Cost of goods $4.1m (FY, 2019) | Cost of goods $59.4m (FY, 2018) | Cost of goods $22m (FY, 2019) | Cost of goods £274.6m (FY, 2019) | Cost of goods $51m (FY, 2019) |
Gross profit | Gross profit $25.4m (FY, 2019) | Gross profit $114.4m (FY, 2018) | Gross profit $160.3m (FY, 2019) | Gross profit £182.3m (FY, 2019) | Gross profit $48.2m (FY, 2019) |
Net income | Net income ($20.6m) (FY, 2019) | Net income ($147.7m) (FY, 2018) | Net income ($356.4m) (FY, 2019) | Net income £5.2m (FY, 2019) | Net income ($18.6m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 88m | Total funding raised N/A | Total funding raised N/A |
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View companyAmicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyA specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
View companyRecro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company